Hesslein Robert W. 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
Hesslein Robert W.
EVP, CLO and Secretary
Transactions
- Award
Common Stock
2024-10-01+7,245→ 7,245 total
Footnotes (1)
- [F1]These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.